During the past decade, New York Total Medical Care PC conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 6 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "New York Total Medical Care PC" are "Crohn's Disease" (3 trials), "Ulcerative Colitis" (3 trials), "Cardiovascular Disease" (2 trials), "Chronic Kidney Diseases" (1 trials) and "Gout" (1 trials). Many other conditions were trialed in "New York Total Medical Care PC" in a lesser frequency.

Most popular intervention types in "New York Total Medical Care PC" are "Drug" (7 trials), "Other" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Ontamalimab" (4 trials), "bococizumab (PF-04950615)" (2 trials), "25 mg Ontamalimab" (1 trials) and "75 mg Ontamalimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "New York Total Medical Care PC" are 8 trials for "All" genders.

Currently, there are NaN active trials in "New York Total Medical Care PC". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in New York Total Medical Care PC, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in New York Total Medical Care PC, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".